Showing results (331-340 of 342) with videos related to
Sort By:
Pageof 35
Nature Communications|June 16, 2019
A global assessment of marine heatwaves and their driversNeil J Holbrook, Hillary A Scannell, Alexander Sen Gupta, et al.Nature Communications|April 12, 2018
Longer and more frequent marine heatwaves over the past centuryEric C J Oliver, Markus G Donat, Michael T Burrows, et al.Journal of Medicinal Chemistry|August 24, 2000
Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agentsI K Khanna, Y Yu, R M Huff, et al.Journal of Medicinal Chemistry|January 5, 1996
Diarylspiro[2.4]heptenes as orally active, highly selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationshipsH C Huang, J J Li, D J Garland, et al.The Journal of Allergy and Clinical Immunology. in Practice|May 25, 2024
The Association of Asthma and Metabolic Dysfunction With Outcomes of Hospitalized Patients With COVID-19Marija Vukoja, Aysun Tekin, Nereida A Parada, et al.JACC. Cardiovascular Interventions|May 25, 2013
Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practiceVasim Farooq, Patrick W Serruys, Jung Ho Heo, et al.Critical Care Medicine|July 27, 2022
Association of Renin Angiotensin Aldosterone System Inhibitors and Outcomes of Hospitalized Patients With COVID-19Neha Gupta, Lisa Settle, Brent R Brown, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2014
Tumorgrafts as in vivo surrogates for women with ovarian cancerS John Weroha, Marc A Becker, Sergio Enderica-Gonzalez, et al.Ecology|July 18, 2013
Do invasive species perform better in their new ranges?John D Parker, Mark E Torchin, Ruth A Hufbauer, et al.Journal of Medicinal Chemistry|April 25, 1997
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib)T D Penning, J J Talley, S R Bertenshaw, et al.Pageof 35